ArticleBMC neurology2026
Correlation between SHR and 28-day all-cause mortality risk in patients with spontaneous intracerebral hemorrhage.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundThe stress hyperglycemia ratio (SHR) has recently been suggested as a dependable indication for predicting adverse outcomes in critically ill ICU patients. Previous studies have primarily focused on cardiovascular disorders include myocardial infarction and coronary artery disease, but the connection between SHR and prognosis in severely ill individuals with cerebrovascular disorders, particularly those with spontaneous intracerebral hemorrhage, remains unclear. This investigation aims to investigate the relationship between SHR and adverse outcomes in critically ill individuals experiencing spontaneous intracerebral hemorrhage.
methodsThis study analyzed information collected from critically ill patients in the MIMIC database, grouped by tertiles of SHR, to demonstrate the clinical characteristics of the different groups of patients. The primary outcome was 28-day all-cause mortality. Cox regression and Kaplan-Meier curves, with restricted cubic spline, were used to investigate the connection between SHR and risk of death in individuals with spontaneous cerebral hemorrhage. Additionally, subgroup analyses were conducted to investigate the effect of different baseline characteristics on the correlation between SHR and risk of death. Lastly, predictive models were constructed using machine learning algorithms to illustrate the predictive efficacy of SHR.
resultsThe study analyzed the data of 815 patients who met the inclusion criteria. The average age of all patients was 69.46 ± 15.05, and 432 patients were male (53.0%). Cox regression analysis demonstrated the connection of SHR with the risk of death as a continuous variable and a categorical variable. Subsequently, Kaplan-Meier curves were generated to illustrate the survival characteristics for the three cohorts of patients(P<0.001). Further restricted cubic splines showed a nonlinear connection between SHR and the risk of death; Higher SHR was significantly correlated with an elevated mortality risk in individuals diagnosed with cerebral hemorrhage (HR>1, p<0.05). In the subgroup analysis, higher SHR was consistently correlated with the mortality risk in the vast majority of subgroups. Finally, five machine learning models were built and ROC were plotted to demonstrate the predictive efficacy of SHR for poor prognosis.
conclusionSHR can be used as an noteworthy predictor of adverse outcome in patients with spontaneous cerebral hemorrhage. Higher SHR is strongly correlated with an elevated risk of unfavorable prognosis, particularly in non-diabetic patients. Additionally, it may help to risk stratify this specific population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.